Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Cash Acquisitions

Bristol-Myers Squibb Company Cash Acquisitions Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Cash Acquisitions from 2010 to 2020.
  • Bristol-Myers Squibb Company Cash Acquisitions for the quarter ending September 09, 2020 was $-243m a -10,013.58% increase of 24,333m year over year
  • Bristol-Myers Squibb Company Cash Acquisitions for the last 12 months ending September 09, 2020 was $-24,997m a 1.45% decrease of -363m year over year
  • Bristol-Myers Squibb Company Annual Cash Acquisitions for 2019 was $-24,634m a 94.94% decrease of -23,388m from 2018
  • Bristol-Myers Squibb Company Annual Cash Acquisitions for 2018 was $-1,246m a 41.73% decrease of -520m from 2017
  • Bristol-Myers Squibb Company Annual Cash Acquisitions for 2017 was $-726m a 50.55% decrease of -367m from 2016
Other Cash Flow Metrics:
  • Bristol-Myers Squibb Company Cash Flow from Operations for the quarter ending September 09, 2018 was $1,279m a 12.67% increase of 162m year over year
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $628m a -33.89% decrease of -213m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Cash Acquisitions Data

09/2020$-243m
06/2020$-153m
03/2020$-25m
12/2019$-24,576m
09/2019$-9m
06/2019$-34m
03/2019$-15m
12/2018$-31m
09/2018$-45m
06/2018$-834m

Annual BMY Cash Acquisitions Data

2019$-24,634m
2018$-1,246m
2017$-726m
2016$-359m
2015$-1,111m
2014$-219m
2012$-7,530m
2011$-360m
2010$-829m